Reply to: Beyond S100B: The need for new biomarkers in stage III melanoma recurrence detection

M R Jansen1, S Caini2, I Stanganelli3

  • 1University of Groningen, University Medical Center Groningen (UMCG), Department of Surgical Oncology, Hanzeplein 1, 9700 RB, Groningen, the Netherlands; University of Parma, Parma University Hospital, Department of Medicine and Surgery, Via Gramsci 14, 43100, Parma, Italy; Institute of Romagna for the Study of Cancer (IRST IRCSS), Skin Cancer Unit, 47014, Meldola, Italy.

Abstract

No abstract available in PubMed .

Related Concept Videos